Stay updated on Safety of Ipilimumab and Nivolumab in Liver Resection Clinical Trial
Sign up to get notified when there's something new on the Safety of Ipilimumab and Nivolumab in Liver Resection Clinical Trial page.

Latest updates to the Safety of Ipilimumab and Nivolumab in Liver Resection Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe study record updated the status to Completed with no longer recruiting and posted results; enrollment is 33 with a completion date of 2026-03-12, and results were first posted on 2026-06-03, accompanied by expanded safety and response-criteria descriptions.SummaryDifference4%

- Check15 days agoChange DetectedThe revision tag on the page advanced from v3.6.0 to v3.6.2, signaling a backend/template update; no study content changes are involved.SummaryDifference0.1%

- Check29 days agoChange DetectedNew navigation/help sections and metadata labels were added, including Last verified, Last known status was:, How to Read a Study Record, Common Questions, How to Join a Study, Intervention/Treatment, and a Revision: v3.6.0 line. The previous labels and formatting (e.g., Intervention / Treatment and Revision: v3.5.5) were replaced or removed.SummaryDifference1%

- Check36 days agoChange DetectedResults Submitted is now shown on the study record, and the page revision is updated to v3.5.5. This reflects that results have been submitted and the record has a newer version.SummaryDifference0.1%

- Check58 days agoChange DetectedVersion tag updated from v3.5.3 to v3.5.4, indicating a new release of the page. It represents an update to the page's metadata rather than a substantive change to the study information.SummaryDifference0.1%

- Check72 days agoChange DetectedRevision: v3.5.3 is now displayed, replacing Revision: v3.5.2 on the page. This indicates a software update to the underlying component, with no changes to study content.SummaryDifference0.1%

Stay in the know with updates to Safety of Ipilimumab and Nivolumab in Liver Resection Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of Ipilimumab and Nivolumab in Liver Resection Clinical Trial page.